Clinical Trials Logo
  1. Home
  2. Hypokalemia
  3. NCT02082717

The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis — Neut-WKBH  

Hypokalemia Clinical Trial

Official title:
The Impact of 4% Sodium Bicarbonate Additive During Potassium Chloride Replacement on Pain and Incidence of Phlebitis for Adult Patients in a Medical Surgical Unit: A Randomized Double Blinded Controlled Study

Clinical Trial Summary

The purpose of this study is to examine the impact of 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy for adult patients in a Medical/Surgical unit. Using a randomized controlled double blinded experimental study design, patients who are 21 years or older are alert, awake, and oriented at the time of enrollment and have been ordered peripheral intravenous potassium chloride replacement will be recruited from one Medical/Surgical during the first 24-48 hours of their admission.

Clinical Trial Description

The specific aim of the study is: Aim 1: To compare patient outcomes (phlebitis, pain at peripheral IV insertion site, frequency of changing IV access, and time for administration) between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups. Aim 2: To compare number and type of nursing interventions done during peripheral intravenous potassium chloride replacement therapy between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups. Aim 3: To compare attrition rates and reasons between the experimental (4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) and control (standard of practice of no 4% sodium bicarbonate additive during peripheral intravenous potassium chloride replacement therapy) groups. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02082717
Study type Interventional
Source Baptist Health South Florida
Contact
Status Terminated
Phase Phase 4
Start date February 25, 2014
Completion date August 3, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT02926989 - Intravenous Fluids in Hospitalised Children Phase 4
Completed NCT00718068 - Safety of Continuous Potassium Chloride Infusion in Critical Care Phase 4
Recruiting NCT04428827 - Outcome of Patients With Primary Aldosteronism
Completed NCT05184998 - Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed NCT01572454 - Comparison of Dexmedetomidine and Remifentanil Infusion During CABG N/A
Not yet recruiting NCT02709031 - Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium Phase 1/Phase 2
Completed NCT04426994 - Hypomagnesemia Associated With Proton-Pump Inhibitor Use
Completed NCT05118022 - Artificial Intelligence Identified Dyskalemia Using Electrocardiogram (AIDE) N/A
Completed NCT00605202 - Effect of Licorice and Hydrochlorothiazide on Plasma Potassium Phase 4
Recruiting NCT02721095 - Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl Phase 4
Recruiting NCT03833089 - Targeted Potassium Levels for Prevention of ICD Therapy Phase 4